Athena Investment Management Has $288,000 Stock Position in Cardinal Health, Inc. $CAH

Athena Investment Management cut its holdings in Cardinal Health, Inc. (NYSE:CAH) by 20.1% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,717 shares of the company’s stock after selling 433 shares during the quarter. Athena Investment Management’s holdings in Cardinal Health were worth $288,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of CAH. Wellington Management Group LLP boosted its stake in shares of Cardinal Health by 1,666.7% in the 1st quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock valued at $328,470,000 after purchasing an additional 2,249,241 shares in the last quarter. JPMorgan Chase & Co. lifted its stake in Cardinal Health by 40.0% in the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock valued at $575,327,000 after purchasing an additional 1,193,983 shares during the last quarter. Zurich Insurance Group Ltd FI boosted its position in Cardinal Health by 4,935.9% in the first quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company’s stock valued at $130,434,000 after buying an additional 927,950 shares in the last quarter. Acadian Asset Management LLC boosted its position in Cardinal Health by 92.5% in the second quarter. Acadian Asset Management LLC now owns 1,679,176 shares of the company’s stock valued at $282,063,000 after buying an additional 807,063 shares in the last quarter. Finally, Nuveen LLC bought a new stake in shares of Cardinal Health during the first quarter worth $106,065,000. Institutional investors own 87.17% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on CAH shares. Weiss Ratings reiterated a “buy (b)” rating on shares of Cardinal Health in a research note on Wednesday, October 8th. UBS Group upped their target price on Cardinal Health from $185.00 to $220.00 and gave the stock a “buy” rating in a report on Friday, October 31st. Evercore ISI increased their target price on Cardinal Health from $190.00 to $220.00 and gave the company an “outperform” rating in a research report on Friday, October 31st. Citigroup lifted their price target on Cardinal Health from $165.00 to $190.00 and gave the company a “neutral” rating in a research note on Friday, October 31st. Finally, Robert W. Baird set a $232.00 price objective on Cardinal Health in a research note on Friday, October 31st. Twelve equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, Cardinal Health presently has a consensus rating of “Moderate Buy” and an average target price of $206.57.

Cardinal Health Stock Performance

NYSE:CAH opened at $207.55 on Thursday. Cardinal Health, Inc. has a fifty-two week low of $114.60 and a fifty-two week high of $209.57. The company has a 50 day simple moving average of $168.98 and a two-hundred day simple moving average of $160.38. The company has a market capitalization of $49.31 billion, a PE ratio of 32.18, a P/E/G ratio of 1.39 and a beta of 0.72.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The firm had revenue of $64.01 billion for the quarter, compared to the consensus estimate of $59.41 billion. During the same quarter in the previous year, the company earned $1.88 EPS. The company’s revenue for the quarter was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Research analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be issued a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date is Friday, January 2nd. Cardinal Health’s dividend payout ratio (DPR) is presently 30.77%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.